Weijie Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Weijie Yang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Anning Zhao
School of Medicine, Zhejiang University, 310028 Hangzhou, Zhejiang, China
1 shared publication - Bofeng Liu
Center for Stem Cell Biology and Regenerative Medicine, MOE Key Laboratory of Bioinformatics, New Cornerstone Science Laboratory, School of Life Sciences, Tsinghua University , Beijing100084
1 shared publication - Chi Zhang
State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University , Nanjing, Jiangsu211166
1 shared publication - Dong Huang
Assisted Reproduction Unit Department of Obstetrics and Gynecology Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou China
1 shared publication - Han Zhao
State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, China.
1 shared publication - Heng-Yu Fan
Life Sciences Institute, Zhejiang University, Hangzhou, China
1 shared publication
Latest Publications
- Open Access
- 10 November 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (21)
Transcription factor 3 cooperates with CXXC finger protein 1 to regulate histone H3K4 trimethylation and developmental competence in mouse oocytes
During oogenesis, the establishment of oocyte-specific gene expression relies on epigenetic and transcriptional remodeling. Both histone modifications and transcription factors are crucial for the oocyte to acquire developmental competence; however, the mechanisms involved remain incompletely understood. Here, we identify transcription factor 3 (TCF3), an E-protein family member, as a key maternal regulator of oocyte developmental potential. Oocyte-specific deletion of Tcf3 results in female infertility, characterized by impaired meiotic maturation and early embryonic arrest at the two-cell stage. These defects are associated with defective maternal mRNA clearance and disrupted establishment of the H3K4me3 landscape in maturing oocytes. Mechanistically, we demonstrate that TCF3 directs H3K4me3 deposition at target gene promoters through interaction with CXXC finger protein 1 (CXXC1), the core subunit of the SETD1 histone methyltransferase complex. Importantly, this TCF3–CXXC1 interaction depends on their DNA-binding activity, highlighting the specificity of TCF3 in coordinating with CXXC1 to regulate maternal target genes, such as Pabpn1l. Together, our findings uncover a transcription factor-driven mechanism of epigenetic reprogramming that is essential for the maternal-to-zygotic transition.
- 10 November 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (21)
Open AccessTranscription factor 3 cooperates with CXXC finger protein 1 to regulate histone H3K4 trimethylation and developmental competence in mouse oocytes
During oogenesis, the establishment of oocyte-specific gene expression relies on epigenetic and transcriptional remodeling. Both histone modifications and transcription factors are crucial for the oocyte to acquire developmental competence; however, the mechanisms involved remain incompletely understood. Here, we identify transcription factor 3 (TCF3), an E-protein family member, as a key maternal regulator of oocyte developmental potential. Oocyte-specific deletion of Tcf3 results in female infertility, characterized by impaired meiotic maturation and early embryonic arrest at the two-cell stage. These defects are associated with defective maternal mRNA clearance and disrupted establishment of the H3K4me3 landscape in maturing oocytes. Mechanistically, we demonstrate that TCF3 directs H3K4me3 deposition at target gene promoters through interaction with CXXC finger protein 1 (CXXC1), the core subunit of the SETD1 histone methyltransferase complex. Importantly, this TCF3–CXXC1 interaction depends on their DNA-binding activity, highlighting the specificity of TCF3 in coordinating with CXXC1 to regulate maternal target genes, such as Pabpn1l. Together, our findings uncover a transcription factor-driven mechanism of epigenetic reprogramming that is essential for the maternal-to-zygotic transition.
- Open Access
- 19 August 2026
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 53 (8)
The Impact of Laparoscopic Versus Open Conservative Surgery for Adenomyosis on Subsequent In Vitro Fertilization Outcomes: A Retrospective Cohort Study
Background:With the widespread adoption of fertility-preserving conservative surgery for adenomyosis in clinical practice, the impact of different surgical approaches on subsequent reproductive outcomes has become a key clinical concern. This study aimed to investigate the impact of laparoscopic versus open conservative surgery for adenomyosis on subsequent in vitro fertilization (IVF) outcomes. Adenomyosis is a recognized cause of female infertility; yet, the optimal surgical approach for patients seeking to preserve fertility remains debated, and comparative data on their effect on subsequent IVF outcomes are limited.Methods:This single-center retrospective cohort study included 162 infertile women with adenomyosis who underwent primary conservative surgery (98 laparoscopic, 64 open) between January 2018 and December 2023. Diagnosis was confirmed by imaging and histopathology. Strict exclusion criteria were applied to minimize confounding. The primary outcome was live birth rate following postoperative IVF. Multivariate logistic regression was used to evaluate the independent effects of surgical approach and intraoperative factors on live birth.Results:Baseline characteristics were comparable between groups, except for a higher proportion of diffuse adenomyosis in the open surgery group (65.6% vs. 28.6%, p < 0.001). As expected, open surgery was associated with longer intraoperative blood loss (103 [55–140] vs. 61 [30–80] mL, p < 0.001), and larger resected lesion volume (40 [22–58] vs. 23 [12–32] cm3, p < 0.001). However, postoperative IVF parameters and pregnancy outcomes showed no significant differences. Clinical pregnancy rates (laparoscopic vs. open: 48.0% vs. 50.0%, p = 0.795) and live birth rates (36.7% vs. 37.5%, p = 0.917) were similar. Multivariate analysis confirmed that surgical approach was not an independent predictor of live birth (adjusted odds ratio [OR] = 1.05, 95% confidence interval [CI]: 0.54–2.04, p = 0.882). Intraoperative blood loss and resection volume were likewise not significantly associated with live birth.Conclusions:Within the limitations of this retrospective design, the choice between laparoscopic and open conservative surgery in infertile patients with adenomyosis was not found to significantly affect subsequent IVF live birth outcomes. Surgical decisions may therefore be guided by individual lesion characteristics and surgeon expertise, as the approach alone does not appear to compromise fertility potential based on the available evidence.
- 19 August 2026
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 53 (8)
Open AccessThe Impact of Laparoscopic Versus Open Conservative Surgery for Adenomyosis on Subsequent In Vitro Fertilization Outcomes: A Retrospective Cohort Study
Background:With the widespread adoption of fertility-preserving conservative surgery for adenomyosis in clinical practice, the impact of different surgical approaches on subsequent reproductive outcomes has become a key clinical concern. This study aimed to investigate the impact of laparoscopic versus open conservative surgery for adenomyosis on subsequent in vitro fertilization (IVF) outcomes. Adenomyosis is a recognized cause of female infertility; yet, the optimal surgical approach for patients seeking to preserve fertility remains debated, and comparative data on their effect on subsequent IVF outcomes are limited.Methods:This single-center retrospective cohort study included 162 infertile women with adenomyosis who underwent primary conservative surgery (98 laparoscopic, 64 open) between January 2018 and December 2023. Diagnosis was confirmed by imaging and histopathology. Strict exclusion criteria were applied to minimize confounding. The primary outcome was live birth rate following postoperative IVF. Multivariate logistic regression was used to evaluate the independent effects of surgical approach and intraoperative factors on live birth.Results:Baseline characteristics were comparable between groups, except for a higher proportion of diffuse adenomyosis in the open surgery group (65.6% vs. 28.6%, p < 0.001). As expected, open surgery was associated with longer intraoperative blood loss (103 [55–140] vs. 61 [30–80] mL, p < 0.001), and larger resected lesion volume (40 [22–58] vs. 23 [12–32] cm3, p < 0.001). However, postoperative IVF parameters and pregnancy outcomes showed no significant differences. Clinical pregnancy rates (laparoscopic vs. open: 48.0% vs. 50.0%, p = 0.795) and live birth rates (36.7% vs. 37.5%, p = 0.917) were similar. Multivariate analysis confirmed that surgical approach was not an independent predictor of live birth (adjusted odds ratio [OR] = 1.05, 95% confidence interval [CI]: 0.54–2.04, p = 0.882). Intraoperative blood loss and resection volume were likewise not significantly associated with live birth.Conclusions:Within the limitations of this retrospective design, the choice between laparoscopic and open conservative surgery in infertile patients with adenomyosis was not found to significantly affect subsequent IVF live birth outcomes. Surgical decisions may therefore be guided by individual lesion characteristics and surgeon expertise, as the approach alone does not appear to compromise fertility potential based on the available evidence.